Evidence map›Paper›PMID 34523263›Full record

ArticleAdvanced healthcare materials2021

Distinct Effects of Heparin and Interleukin-4 Functionalization on Macrophage Polarization and In Situ Arterial Tissue Regeneration Using Resorbable Supramolecular Vascular Grafts in Rats.

Valentina Bonito, Suzanne E Koch, Merle M Krebber, Daniel A Carvajal-Berrio, Julia Marzi, Renee Duijvelshoff, Emily B Lurier, Serena Buscone, Sylvia Dekker, Simone M J de Jong and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Advanced healthcare materials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Engineering the Immune Response to Biomaterials.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Marker-Independent Monitoring ofFrontiers in cardiovascular medicine · 2022
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 3 countries.

Valentina BonitoDepartment of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, 5600 MB, The Netherlands.ORCID 0000-0002-6810-5138
Suzanne E KochDepartment of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, 5600 MB, The Netherlands.ORCID 0000-0003-1521-4768
Merle M KrebberDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands.ORCID 0000-0001-9856-6907
Daniel A Carvajal-BerrioDepartment of Biomedical Engineering, Research Institute of Women's Health and Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University Tübingen, Tübingen, 72076, Germany.ORCID 0000-0003-0254-0281
Julia MarziDepartment of Biomedical Engineering, Research Institute of Women's Health and Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University Tübingen, Tübingen, 72076, Germany.ORCID 0000-0003-1545-5430
Renee DuijvelshoffDepartment of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, 5600 MB, The Netherlands.ORCID 0000-0003-1610-5133
Emily B LurierDepartment of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, 5600 MB, The Netherlands.
Serena BusconeDepartment of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, 5600 MB, The Netherlands.ORCID 0000-0002-5342-2149
Sylvia DekkerDepartment of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, 5600 MB, The Netherlands.
Simone M J de JongDepartment of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, 5600 MB, The Netherlands.
Tristan MesSupraPolix BV, Eindhoven, 5612 AX, The Netherlands.
Koen R D VaessenCentral Laboratory Animal Research Facility (CLARF), Utrecht University, Utrecht, 3584 CX, The Netherlands.ORCID 0000-0002-0916-8075
Eva M BrauchleDepartment of Biomedical Engineering, Research Institute of Women's Health and Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University Tübingen, Tübingen, 72076, Germany.ORCID 0000-0001-9208-5010
Anton W BosmanSupraPolix BV, Eindhoven, 5612 AX, The Netherlands.ORCID 0000-0002-0744-9965
Katja Schenke-LaylandDepartment of Biomedical Engineering, Research Institute of Women's Health and Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University Tübingen, Tübingen, 72076, Germany.ORCID 0000-0001-8066-5157
Marianne C VerhaarDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands.ORCID 0000-0002-3276-6428
Patricia Y W DankersDepartment of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, 5600 MB, The Netherlands.ORCID 0000-0002-8997-181X
Anthal I P M SmitsDepartment of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, 5600 MB, The Netherlands.ORCID 0000-0002-3665-7106
Carlijn V C BoutenDepartment of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, 5600 MB, The Netherlands.ORCID 0000-0003-1035-5094
Eindhoven University of Technology · NLNatural and Medical Sciences Institute · DEUtrecht University · NLSupraPolix (Netherlands) · NLDrexel University · USIsala · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two of the greatest challenges for successful application of small-diameter in situ tissue-engineered vascular grafts are 1) preventing thrombus formation and 2) harnessing the inflammatory response to the graft to guide functional tissue regeneration. This study evaluates the in vivo performance of electrospun resorbable elastomeric vascular grafts, dual-functionalized with anti-thrombogenic heparin (hep) and anti-inflammatory interleukin 4 (IL-4) using a supramolecular approach. The regenerative capacity of IL-4/hep, hep-only, and bare grafts is investigated as interposition graft in the rat abdominal aorta, with follow-up at key timepoints in the healing cascade (1, 3, 7 days, and 3 months). Routine analyses are augmented with Raman microspectroscopy, in order to acquire the local molecular fingerprints of the resorbing scaffold and developing tissue. Thrombosis is found not to be a confounding factor in any of the groups. Hep-only-functionalized grafts resulted in adverse tissue remodeling, with cases of local intimal hyperplasia. This is negated with the addition of IL-4, which promoted M2 macrophage polarization and more mature neotissue formation. This study shows that with bioactive functionalization, the early inflammatory response can be modulated and affect the composition of neotissue. Nevertheless, variability between graft outcomes is observed within each group, warranting further evaluation in light of clinical translation.

Indexed as

Blood Vessel ProsthesisInterleukin-4AnimalsHeparinMacrophagesRatsTissue EngineeringTissue ScaffoldsHeparinInterleukin-4biodegradable polymerscardiovascularimmunomodulatory biomaterialsin situ tissue engineeringRaman microspectroscopysupramolecular chemistrytissue-engineered vascular graft (TEVG)

Identifiers

PMID34523263
PMCPMC11469141
OpenAlexW3200549350

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.